Screening and identification of a renal carcinoma specific peptide from a phage display peptide library

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Tu, Xiangan ^a   Zhuang, Jintao ^a   Wang, Wenwei ^a   Zhao, Liang ^a   Zhao, Liangyun ^a   Zhao, Jiquan ^a   Deng, Chunhua ^a   Qiu, Shaopeng ^a   Zhang, Yuanyuan ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Peptide; Phage display; Renal cell carcinoma; Targeting

Indexed keywords

PEPTIDE LIBRARY; OLIGOPEPTIDE; PEPTIDE; PEPTIDE ZT 2; PEPTIDE ZT-2;

ARTICLE; BINDING AFFINITY; CANCER SCREENING; CELL SURFACE; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY CARCINOMA; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FOLDING; TARGET CELL; TUMOR CELL; AMINO ACID SEQUENCE; BINDING COMPETITION; CELL LINE; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; KIDNEY TUMOR; METABOLISM; PEPTIDE LIBRARY;

AMINO ACID SEQUENCE; BINDING, COMPETITIVE; CARCINOMA, RENAL CELL; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; KIDNEY NEOPLASMS; OLIGOPEPTIDES; PEPTIDE LIBRARY; PEPTIDES; PROTEIN BINDING;

EID: 80755142992     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-105     Document Type: Article

References (15)

1. Cancer statistics, CA Cancer. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ, J Clin 2009 2009 59 4 225 249
2. Management of solid renal tumour associated with von Hippel-Lindau disease. Zhang J, Huang YR, Liu DM, Zhou LX, Xue W, Chen Q, Dong BJ, Pan JH, Xuan HQ, Chin Med J 2007 120 22 2049 2052 18067796 (Pubitemid 350237817)
3. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. Flanigan RC, Salmon SE, Blumenstein BA, Bearman SI, Roy V, McGrath PC, Caton JR Jr, Munshi N, Crawford ED, N Engl J Med 2001 345 23 1655 1659 10.1056/NEJMoa003013 11759643 (Pubitemid 33126820)
4. Renal-cell carcinoma. Cohen HT, McGovern FJ, N Engl J Med 2005 353 23 2477 2490 10.1056/NEJMra043172 16339096 (Pubitemid 41770167)
5. Diagnostic and prognostic molecular markers in renal cell carcinoma. Tunuguntla HS, Jorda M, J Urol 2008 179 6 2096 2102 10.1016/j.juro.2008.01.083 18423738
6. Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability. Eichelberg C, Junker K, Ljungberg B, Moch H, Eur Urol 2009 55 4 851 863 10.1016/j.eururo.2009.01.003 19155123
7. Phage display: concept, innovations, applications and future. Pande J, Szewczyk MM, Grover AK, Biotechnol Adv 2010 28 6 849 858 10.1016/j.biotechadv. 2010.07.004 20659548
8. Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide presenting phage libraries. Barry MA, Dower WJ, Johnston SA, Nat Med 1996 2 3 299 305 10.1038/nm0396-299 8612228 (Pubitemid 26080650)
9. Phage-display selection of peptides that affect prostate carcinoma cells attachment and invasion. Romanov VI, Durand DB, Petrenko VA, Prostate 2001 47 4 239 251 10.1002/pros.1068 11398171 (Pubitemid 32521743)
10. Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells. Shadidi M, Sioud M, FASEB J 2003 17 2 256 258 12490548
11. In vitro panning of a targeting peptide to NCI-H1299 from a phage display peptide library. Du B, Qian M, Zhou ZL, Wang P, Wang L, Zhang X, Wu M, Zhang P, Mei B, Biochem Biophys Res Comm 2006 32 3 956 962 (Pubitemid 43320490)
12. Immunohistochemical analysis of the expression of FATE/BJ-HCC-2 antigen in normal and malignant tissues. Yang XA, Dong XY, Qiao H, Wang YD, Peng JR, Li Y, Pang XW, Tian C, Chen WF, Lab Invest 2005 85 2 205 213 10.1038/labinvest. 3700220 15580283 (Pubitemid 40208924)
13. A pilot study of monoclonal antibody cG250 and low dose subcutaneous IL-2 in patients with advanced renal cell carcinoma. Davis ID, Liu Z, Saunders W, Lee FT, Spirkoska V, Hopkins W, Smyth FE, Chong G, Papenfuss AT, Chappell B, Poon A, Saunder TH, Hoffman EW, Old LJ, Scott AM, Cancer Immun 2007 7 13 17705349
14. Unique biological properties of catalytic domain directed human anti-CAIX antibodies discovered through phage-display technology. Xu C, Lo A, Yammanuru A, Tallarico AS, Brady K, Murakami A, Barteneva N, Zhu Q, Marasco WA, PLoS One 2010 5 3 9625 10.1371/journal.pone.0009625 20224781
15. Peptides as carrier for tumor diagnosis and treatment. Langer M, Beck-Sickinger AG, Curr Med Chem Anticancer Agents 2001 1 1 71 93 10.2174/1568011013354877 12678771